Statin use and all-cause and cancer mortality: BioBank Japan cohort

被引:24
|
作者
Yokomichi, Hiroshi [1 ]
Nagai, Akiko [2 ]
Hirata, Makoto [3 ]
Tamakoshi, Akiko [4 ]
Kiyohara, Yutaka [5 ]
Kamatani, Yoichiro [6 ]
Muto, Kaori [2 ]
Ninomiya, Toshiharu [7 ]
Matsuda, Koichi [8 ]
Kubo, Michiaki [9 ]
Nakamura, Yusuke [8 ]
Yamagata, Zentaro [1 ]
机构
[1] Univ Yamanashi, Dept Hlth Sci, 1110 Shimokato, Chuo City, Yamanashi 4093898, Japan
[2] Univ Tokyo, Inst Med Sci, Dept Publ Policy, Tokyo, Japan
[3] Univ Tokyo, Inst Med Sci, Lab Genome Technol, Tokyo, Japan
[4] Hokkaido Univ, Dept Publ Hlth, Grad Sch Med, Sapporo, Hokkaido, Japan
[5] Hisayama Res Inst Lifestyle Dis, Fukuoka, Japan
[6] RIKEN, Lab Stat Anal, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan
[7] Kyushu Univ, Grad Sch Med Sci, Dept Epidemiol & Publ Hlth, Fukuoka, Japan
[8] Univ Tokyo, Inst Med Sci, Mol Med Lab, Tokyo, Japan
[9] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan
关键词
Dyslipidaemia; Statins; Anti-cholesterol agents; Colon cancer; Kaplane-Meier estimate; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE; LDL CHOLESTEROL; RISK; METAANALYSIS; THERAPY; GUIDELINES; EZETIMIBE; SURVIVAL; EFFICACY;
D O I
10.1016/j.je.2016.12.011
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Statins are the first-line agents used to treat patients with high serum low-density lipoprotein cholesterol levels, thus reducing the risk of death from arterial sclerotic cardiovascular disease; however, little is known about the effects of non-statin pharmacological interventions on mortality as well as about the potential protective effects of statin use against cancer death. This work aimed to compare all-cause and cancer mortality among patients with hyperlipidaemia who did and did not receive statin treatment. Methods: Between 2003 and 2007 fiscal years, we recruited Japanese patients diagnosed with hyperlipidaemia from 66 hospitals. Patients in our cohort were followed up for a maximum of 12 years to observe the causes of death. Kaplan-Meier estimates from the baseline were used to compare the mortality of patients based on the administered medicine. All-cause mortality were compared among patients with/without administration of statins and other agents; any-organ and colorectal cancer mortality were compared between patients with/without administration of statins. Results: Our cohort included 41,930 patients with mean ages of 64-66 years and mean body mass indices of 24-25 kg/m(2). Patients who received statin monotherapy and were treated with lifestyle modification exhibited nearly identical survival curves, whereas statin use represented a non-significant but potentially protective effect against colorectal cancer-related mortality. The lowest mortality in this cohort was associated with resin monotherapy. Conclusions: Mortality rate has been similar for patients treated with statin monotherapy and lifestyle modification. Statin monotherapy could potentially reduceany-organ-andcolorectal cancer-relatedmortality. (C) 2017 The Authors. Publishing services by Elsevier B.V. on behalf of The Japan Epidemiological Association.
引用
收藏
页码:S84 / S91
页数:8
相关论文
共 50 条
  • [41] Sleep disorder, Mediterranean diet, and all-cause and cause-specific mortality: a prospective cohort study
    Wang, Yongle
    Fan, Hongxuan
    Ren, Zhaoyu
    Liu, Xuchang
    Niu, Xiaoyuan
    BMC PUBLIC HEALTH, 2023, 23 (01)
  • [42] Statin Use and All-Cause Mortality in Nursing Home Residents With and Without Dementia A Retrospective Cohort Study Using Claims Data
    O'Sullivan, Julie Lorraine
    Kohl, Raphael
    Lech, Sonia
    Romanescu, Laura
    Schuster, Johanna
    Kuhlmey, Adelheid
    Gellert, Paul
    Yasar, Sevil
    NEUROLOGY, 2024, 102 (06) : e209189
  • [43] Tea Consumption and All-Cause and Cause-Specific Mortality in the UK Biobank In Response
    Inoue-Choi, Maki
    Ramirez, Yesenia
    Freedman, Neal D.
    Loftfield, Erikka
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (02)
  • [44] Tea Consumption and All-Cause and Cause-Specific Mortality in the UK Biobank Comment
    Nishiyama, Yasutaka
    Fujikawa, Tatsuya
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (02)
  • [45] Statin Use is Associated with Reduced All-Cause Mortality Following Bioprosthetic Heart Valve Implantation
    Albaghdadi, Mazen S.
    Andrei, Adin-Christian
    Li, Zhi
    Kruse, Jane
    McDonald, Eileen
    Bonow, Robert
    McCarthy, Patrick
    CIRCULATION, 2014, 130
  • [46] Purine Intake and All-Cause Mortality in Ovarian Cancer: Results from a Prospective Cohort Study
    Du, Zongda
    Gong, Tingting
    Wei, Yifan
    Zheng, Gang
    Zhao, Junqi
    Zou, Bingjie
    Qin, Xue
    Yan, Shi
    Liu, Fanghua
    Xiao, Qian
    Wu, Qijun
    Gao, Song
    Zhao, Yuhong
    NUTRIENTS, 2023, 15 (04)
  • [47] Association of NAFLD with cardiovascular disease and all-cause mortality: a large-scale prospective cohort study based on UK Biobank
    Ma, Wen
    Wu, Wentao
    Wen, Weixing
    Xu, Fengshuo
    Han, Didi
    Lyu, Jun
    Huang, Yuli
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2022, 13
  • [48] Associations of Oral Contraceptive Use With Cardiovascular Disease and All-Cause Death: Evidence From the UK Biobank Cohort Study
    Dou, Weijuan
    Huang, Yan
    Liu, Xuesong
    Huang, Chensihan
    Huang, Junlin
    Xu, Bingyan
    Yang, Linjie
    Liu, Yating
    Lei, Xuzhen
    Li, Xu
    Huang, Junfeng
    Lin, Jiayang
    Liu, Deying
    Zhang, Peizhen
    Shao, Jiaqing
    Liu, Changqin
    Zhang, Huijie
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (16):
  • [49] Rheumatoid factor positivity increases all-cause and cancer mortality: a cohort study
    Joong Kyong Ahn
    Jiwon Hwang
    Yoosoo Chang
    Seungho Ryu
    Rheumatology International, 2017, 37 : 1135 - 1143
  • [50] The Cohort Study on Prediction of Incidence of All-Cause Mortality by Metabolic Syndrome
    Li, Zhixia
    Yang, Xinghua
    Yang, Jun
    Yang, Zhirong
    Wang, Shengfeng
    Sun, Feng
    Zhan, Siyan
    PLOS ONE, 2016, 11 (05):